Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription Articles published in Radiology Retrieve available abstracts of 97 articles: HTML format

Single Articles

October 2025
1. PARK VY, Choi JS, Han K, Nahm S, et al
   Imaging Features and Diagnostic Performance of US in Nonmass Lesions with Varying Clinical Indications.
   Radiology. 2025;317:e243398.
   PubMed     Abstract available
   
   
   September 2025
2. KIM HJ, Chae EY, Eom HJ, Choi WJ, et al
   Node Reporting and Data System Evaluation of Axillary Nodes in Invasive Ductal and Lobular Carcinoma.
   Radiology. 2025;316:e243823.
   PubMed     Abstract available
   
   
   
3. FREITAS V
   Node Reporting and Data System in Focus: Advancing Precision in Axillary Staging for Breast Cancer.
   Radiology. 2025;316:e252033.
   PubMed    
   
   
   
4. KO ES, Yu JH, Woo SY, Kim SW, et al
   Calcifications Affect Pathologic Complete Response and MRI Prediction after Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-positive Breast Cancer.
   Radiology. 2025;316:e250718.
   PubMed     Abstract available
   
   
   
5. MESUROLLE B, El Khoury M
   False-Positive Recall and Biopsy Rates in Breast Cancer Screening: Insights from TOSYMA.
   Radiology. 2025;316:e252367.
   PubMed    
   
   
   
6. WEIGEL S, Hense HW, Weyer-Elberich V, Gerss J, et al
   False-Positive Recall and False-Positive Biopsy Rates in Mammography Screening: A TOSYMA Trial Subanalysis.
   Radiology. 2025;316:e251014.
   PubMed     Abstract available
   
   
   
7. HRUSKA CB, Hunt KN, Larson NB, Miller PA, et al
   Molecular Breast Imaging and Digital Breast Tomosynthesis for Dense Breast Screening: The Density MATTERS Trial.
   Radiology. 2025;316:e243953.
   PubMed     Abstract available
   
   
   
8. KO ES, Yu JH, Woo SY, Kim SW, et al
   Erratum for: Calcifications Affect Pathologic Complete Response and MRI Prediction after Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-positive Breast Cancer.
   Radiology. 2025;316:e259015.
   PubMed    
   
   
   August 2025
9. ULANER GA
   Detection of Oligometastatic Disease in Breast Cancer: It's the Little Things That Count.
   Radiology. 2025;316:e251797.
   PubMed    
   
   
   
10. YEH R, D'Andrea G
    In Vivo Imaging for Assessing Receptor Status in Breast Cancer.
    Radiology. 2025;316:e243832.
    PubMed    
    
    
    
11. METSER U, Ali Mirshahvalad S, Dayes IS, Parpia S, et al
    (18)F-FDG PET/CT of Oligometastatic Disease in Locally Advanced Breast Cancer: PETABC Trial Post Hoc Analysis.
    Radiology. 2025;316:e243788.
    PubMed     Abstract available
    
    
    
12. CHEN Y, Partridge GJW, Vazirabad M, Ball RL, et al
    Performance of Algorithms Submitted in the 2023 RSNA Screening Mammography Breast Cancer Detection AI Challenge.
    Radiology. 2025;316:e241447.
    PubMed     Abstract available
    
    
    
13. VERBOOM SD, Kroes J, Pires S, Broeders MJM, et al
    AI Should Read Mammograms Only When Confident: A Hybrid Breast Cancer Screening Reading Strategy.
    Radiology. 2025;316:e242594.
    PubMed     Abstract available
    
    
    
14. WOOLDRIK SM, van de Voort EMF, Struik GM, Schouten BJM, et al
    Percutaneous Thermal Ablation for Early-Stage Breast Cancer: An Open-Label, Randomized, Phase II Trial to Select the Preferred Technique for Evaluating Thermal Ablation as a Surgical Alternative.
    Radiology. 2025;316:e243386.
    PubMed    
    
    
    
15. HUANG Y, Song X, Chen Y, Qiu H, et al
    Intratumoral Microbiome-related MRI Model for Predicting Breast Cancer Shrinkage Pattern Following Neoadjuvant Therapy.
    Radiology. 2025;316:e243545.
    PubMed     Abstract available
    
    
    July 2025
16. ONISHI N
    Breast MRI for Assessing Triple-Negative Breast Cancer after Neoadjuvant Chemoimmunotherapy.
    Radiology. 2025;316:e251503.
    PubMed    
    
    
    
17. RAMTOHUL T, Lollivier D, Spriet J, Jin M, et al
    Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.
    Radiology. 2025;316:e243824.
    PubMed     Abstract available
    
    
    
18. GOMMERS JJJ, Verboom SD, Duvivier KM, van Rooden CJ, et al
    Influence of AI Decision Support on Radiologists' Performance and Visual Search in Screening Mammography.
    Radiology. 2025;316:e243688.
    PubMed     Abstract available
    
    
    
19. OVIEDO F, Kazerouni AS, Liznerski P, Xu Y, et al
    Cancer Detection in Breast MRI Screening via Explainable AI Anomaly Detection.
    Radiology. 2025;316:e241629.
    PubMed     Abstract available
    
    
    
20. BAE MS, Ham S
    Explainable AI in MRI for Breast Cancer Detection: Another Step Forward.
    Radiology. 2025;316:e251790.
    PubMed    
    
    
    
21. GONG X, Wang X, Wang L, Zeng X, et al
    Comparing Multi-b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Radiology. 2025;316:e242969.
    PubMed     Abstract available
    
    
    
22. THAKUR SB, Bitencourt AGV
    Precision Imaging in Breast Cancer: Neoadjuvant Chemotherapy Monitoring with Advanced Diffusion MRI.
    Radiology. 2025;316:e251723.
    PubMed    
    
    
    
23. BAHL M, Langarica S, Lamb LR, Kniss AS, et al
    AI to Reduce the Interval Cancer Rate of Screening Digital Breast Tomosynthesis.
    Radiology. 2025;316:e241050.
    PubMed     Abstract available
    
    
    
24. LEE CI, Milch HS
    Clinically Meaningful AI Detection of Interval Breast Cancer at Digital Breast Tomosynthesis Screening.
    Radiology. 2025;316:e251860.
    PubMed    
    
    
    June 2025
25. ESKREIS-WINKLER S, Bhowmik A, Kelly LH, Lo Gullo R, et al
    Adaptive Breast MRI Scanning Using AI.
    Radiology. 2025;315:e242924.
    PubMed     Abstract available
    
    
    
26. HONDA M, Iima M
    Preoperative Diffusion-weighted Imaging to Reduce the Burden on Patients with Breast Cancer.
    Radiology. 2025;315:e250964.
    PubMed    
    
    
    
27. KIM HJ, Partridge SC, Lee J, Yoen H, et al
    Preoperative Diagnosis of Ipsilateral and Contralateral Breast Cancer: Role of Diffusion-weighted MRI.
    Radiology. 2025;315:e242423.
    PubMed     Abstract available
    
    
    
28. BERG WA, Vargo A, Lu AH, Berg JM, et al
    Screening for Breast Cancer with Contrast-enhanced Mammography as an Alternative to MRI: SCEMAM Trial Results.
    Radiology. 2025;315:e242634.
    PubMed     Abstract available
    
    
    
29. KIM HJ, Partridge SC, Lee J, Yoen H, et al
    Erratum for: Preoperative Diagnosis of Ipsilateral and Contralateral Breast Cancer: Role of Diffusion-weighted MRI.
    Radiology. 2025;315:e259012.
    PubMed    
    
    
    
30. WOO OH, Song SE, Choe SJ, Kim M, et al
    Invasive Breast Cancers Missed by AI Screening of Mammograms.
    Radiology. 2025;315:e242408.
    PubMed     Abstract available
    
    
    May 2025
31. BODE M, Morscheid S, Iordanishvili E, Huck LC, et al
    Intraindividual Comparison of Ultrafast versus Standard Two-dimensional Dynamic Contrast-enhanced Breast MRI.
    Radiology. 2025;315:e241371.
    PubMed     Abstract available
    
    
    
32. WINHAM SJ, McCarthy AM, Scott CG, Gastounioti A, et al
    Radiomic Parenchymal Phenotypes of Breast Texture from Mammography and Association with Risk of Breast Cancer.
    Radiology. 2025;315:e240281.
    PubMed     Abstract available
    
    
    
33. MESUROLLE B, El Khoury M
    Breast Cancer Risk Prediction with Radiomic Tissue Characterization on Mammograms Takes Shape.
    Radiology. 2025;315:e250622.
    PubMed    
    
    
    
34. VAN GRINSVEN SEL, Mann RM, Monninkhof EM, Duvivier K, et al
    Multireader Diagnostic Accuracy of Abbreviated Breast MRI for Screening Women with Extremely Dense Breasts.
    Radiology. 2025;315:e241233.
    PubMed     Abstract available
    
    
    
35. BECHYNA S, Baltzer PAT
    Impact of Background Parenchymal Enhancement on Diagnostic Performance of Breast MRI: A Systematic Review and Meta-Analysis.
    Radiology. 2025;315:e241919.
    PubMed     Abstract available
    
    
    April 2025
36. SLAVKOVA KP, Kang R, Kazerouni AS, Biswas D, et al
    MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Radiology. 2025;315:e241628.
    PubMed     Abstract available
    
    
    
37. HA SM, Lee JM, Jang MJ, Kim HK, et al
    Breast Cancer Detection with Standalone AI versus Radiologist Interpretation of Unilateral Surveillance Mammography after Mastectomy.
    Radiology. 2025;315:e242955.
    PubMed     Abstract available
    
    
    
38. HUANG Y, Wang X, Cao Y, Lan X, et al
    Nomogram for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Using MRI-based Intratumoral Heterogeneity Quantification.
    Radiology. 2025;315:e241805.
    PubMed     Abstract available
    
    
    
39. AUTIER P, Burrion JB, Grivegnee A
    Artificial Intelligence System for Interval Breast Cancer Detection May Swamp Screening Programs.
    Radiology. 2025;315:e242698.
    PubMed    
    
    
    
40. KIM HJ, Choi WJ, Eom HJ, Chae EY, et al
    Impact of Preoperative MRI on Survival Outcomes in Patients with HER2-positive and Hormone Receptor-negative Breast Cancer.
    Radiology. 2025;315:e242712.
    PubMed     Abstract available
    
    
    
41. IMBRIACO M, Ponsiglione A
    Preoperative MRI and Long-term Outcomes in Patients with HER2-positive and Hormone Receptor-negative Breast Cancer: A Matched Cohort Study.
    Radiology. 2025;315:e250532.
    PubMed    
    
    
    March 2025
42. KNIP JJ, Iqbal R, Bonjer EC, Mammatas LH, et al
    The Diagnostic Accuracy of (18)F-FDG PET and (18)F-FES PET for Staging Grade 1-2 Estrogen Receptor-Positive Breast Cancer.
    Radiology. 2025;314:e241850.
    PubMed     Abstract available
    
    
    
43. FOWLER AM
    (18)F-Fluoroestradiol PET/CT for Staging Low-Grade Estrogen Receptor-Positive Breast Cancer.
    Radiology. 2025;314:e250135.
    PubMed    
    
    
    
44. DEMBROWER KE, Crippa A, Eklund M, Strand F, et al
    Human-AI Interaction in the ScreenTrustCAD Trial: Recall Proportion and Positive Predictive Value Related to Screening Mammograms Flagged by AI CAD versus a Human Reader.
    Radiology. 2025;314:e242566.
    PubMed     Abstract available
    
    
    
45. HORVAT JV, Amir T, Watt GP, Comstock CE, et al
    Comparison of Contrast-enhanced Mammography and Low-Energy Imaging with or without Supplemental Whole-Breast US in Breast Cancer Detection.
    Radiology. 2025;314:e242006.
    PubMed     Abstract available
    
    
    February 2025
46. VAN WINKEL SL, Samperna R, Loehrer EA, Kroes J, et al
    Using AI to Select Women with Intermediate Breast Cancer Risk for Breast Screening with MRI.
    Radiology. 2025;314:e233067.
    PubMed     Abstract available
    
    
    
47. NISSAN N, Sevilimedu V, Gluskin J, Arita Y, et al
    Hormonal Regulation of Background Parenchymal Enhancement at Contrast-enhanced Mammography.
    Radiology. 2025;314:e241158.
    PubMed     Abstract available
    
    
    
48. LAWSON MB, Zhu W, Miglioretti DL, Onega T, et al
    Disparities in Standard-of-Care, Advanced, and Same-Day Diagnostic Services among Patients with Abnormal Screening Mammography.
    Radiology. 2025;314:e241673.
    PubMed     Abstract available
    
    
    January 2025
49. YOON J, Han K, Nahm S, Kim MJ, et al
    Surveillance Breast MRI in Women with a History of Breast Cancer: Association with Occurrence of Advanced Second Breast Cancer.
    Radiology. 2025;314:e240119.
    PubMed     Abstract available
    
    
    December 2024
50. KIM E, Moy L
    Distant-Stage Breast Cancer Incidence Is Increasing in U.S. Women across Age Groups and Race and Ethnicity Groups.
    Radiology. 2024;313:e242716.
    PubMed    
    
    
    
51. HENDRICK RE, Monticciolo DL
    Surveillance, Epidemiology, and End Results Data Show Increasing Rates of Distant-Stage Breast Cancer at Presentation in U.S. Women.
    Radiology. 2024;313:e241397.
    PubMed     Abstract available
    
    
    November 2024
52. HA SM, Choi WJ, Han BK, Kim HH, et al
    Assessment of Nonmass Lesions Detected with Screening Breast US Based on Mammographic Findings.
    Radiology. 2024;313:e240043.
    PubMed     Abstract available
    
    
    
53. ABBEY CK, Bandos AI, Parthasarathy MK, Webster MA, et al
    Changes in Reader Performance During Sequential Reading of Breast Cancer Screening Digital Breast Tomosynthesis Examinations.
    Radiology. 2024;313:e232885.
    PubMed     Abstract available
    
    
    
54. HICKMAN SE, Payne NR, Black RT, Huang Y, et al
    Deep Learning Algorithms for Breast Cancer Detection in a UK Screening Cohort: As Stand-alone Readers and Combined with Human Readers.
    Radiology. 2024;313:e233147.
    PubMed     Abstract available
    
    
    October 2024
55. NISSAN N, Comstock CE, Sevilimedu V, Gluskin J, et al
    Diagnostic Accuracy of Screening Contrast-enhanced Mammography for Women with Extremely Dense Breasts at Increased Risk of Breast Cancer.
    Radiology. 2024;313:e232580.
    PubMed     Abstract available
    
    
    
56. LOBBES MBI
    A Decade of Contrast-enhanced Mammography: Expanding Screening to Women at Intermediate or High Risk for Breast Cancer.
    Radiology. 2024;313:e241970.
    PubMed    
    
    
    
57. TRENTHAM-DIETZ A
    Weighing the Benefits and Risks of Mammography Screening Strategies.
    Radiology. 2024;313:e240819.
    PubMed    
    
    
    
58. GRIMM LJ
    A New Paradigm for Reading Screening Mammograms.
    Radiology. 2024;313:e242141.
    PubMed    
    
    
    
59. GOMMERS JJJ, Verboom SD, Duvivier KM, van Rooden JK, et al
    Enhancing Radiologist Reading Performance by Ordering Screening Mammograms Based on Characteristics That Promote Visual Adaptation.
    Radiology. 2024;313:e240237.
    PubMed     Abstract available
    
    
    
60. PARTRIDGE SC, Xu J
    Cellular Characterization of Breast Cancer Using Microstructural Diffusion MRI.
    Radiology. 2024;313:e242268.
    PubMed    
    
    
    
61. WANG X, Ba R, Huang Y, Cao Y, et al
    Time-Dependent Diffusion MRI Helps Predict Molecular Subtypes and Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Radiology. 2024;313:e240288.
    PubMed     Abstract available
    
    
    September 2024
62. RAMTOHUL T, Lepagney V, Bonneau C, Jin M, et al
    Use of Pretreatment Perfusion MRI-based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.
    Radiology. 2024;312:e240575.
    PubMed     Abstract available
    
    
    
63. RAUCH GM
    Biomarkers for Personalized Neoadjuvant Therapy in Triple-Negative Breast Cancer: Moving Forward.
    Radiology. 2024;312:e242011.
    PubMed    
    
    
    
64. BAHL M
    Combining AI and Radiomics to Improve the Accuracy of Breast US.
    Radiology. 2024;312:e241795.
    PubMed    
    
    
    
65. MAGNUSKA ZA, Roy R, Palmowski M, Kohlen M, et al
    Combining Radiomics and Autoencoders to Distinguish Benign and Malignant Breast Tumors on US Images.
    Radiology. 2024;312:e232554.
    PubMed     Abstract available
    
    
    
66. KIM SY, Woo OH
    Implications of Digital Breast Tomosynthesis in Breast Cancer Screening: Reducing Advanced Breast Cancers.
    Radiology. 2024;312:e242008.
    PubMed    
    
    
    
67. PHILPOTTS LE, Grewal JK, Horvath LJ, Giwerc MY, et al
    Breast Cancers Detected during a Decade of Screening with Digital Breast Tomosynthesis: Comparison with Digital Mammography.
    Radiology. 2024;312:e232841.
    PubMed     Abstract available
    
    
    August 2024
68. SPRAGUE BL, Ichikawa L, Eavey J, Lowry KP, et al
    Performance of Supplemental US Screening in Women with Dense Breasts and Varying Breast Cancer Risk: Results from the Breast Cancer Surveillance Consortium.
    Radiology. 2024;312:e232380.
    PubMed     Abstract available
    
    
    
69. HELBICH TH, Kapetas P
    Gradualism: How Supplemental Breast Cancer Screening Will Become a Reality.
    Radiology. 2024;312:e241563.
    PubMed    
    
    
    
70. ZHOU W, Franc BL, DeMartini WB, Rosen EL, et al
    Estrogen Receptor-targeted PET Imaging for Breast Cancer.
    Radiology. 2024;312:e240315.
    PubMed     Abstract available
    
    
    
71. VAN DER WAAL D, van Landsveld-Verhoeven C, Tetteroo E, van Engen RE, et al
    Pain Experience and Image Quality with Curved versus Standard Compression for Breast Cancer Screening Mammography: A Randomized Controlled Trial.
    Radiology. 2024;312:e232680.
    PubMed     Abstract available
    
    
    
72. HELBICH TH, Kapetas P
    Erratum for: Gradualism: How Supplemental Breast Cancer Screening Will Become a Reality.
    Radiology. 2024;312:e249019.
    PubMed    
    
    
    
73. NANAA M, Gupta VO, Hickman SE, Allajbeu I, et al
    Accuracy of an Artificial Intelligence System for Interval Breast Cancer Detection at Screening Mammography.
    Radiology. 2024;312:e232303.
    PubMed     Abstract available
    
    
    July 2024
74. MULLER-FRANZES G, Khader F, Tayebi Arasteh S, Huck L, et al
    Intraindividual Comparison of Different Methods for Automated BPE Assessment at Breast MRI: A Call for Standardization.
    Radiology. 2024;312:e232304.
    PubMed     Abstract available
    
    
    
75. HA SM, Jang MJ, Youn I, Yoen H, et al
    Screening Outcomes of Mammography with AI in Dense Breasts: A Comparative Study with Supplemental Screening US.
    Radiology. 2024;312:e233391.
    PubMed     Abstract available
    
    
    
76. WHITMAN GJ, Destounis SV
    Screening Mammography with AI and Supplemental Breast US: Current Status.
    Radiology. 2024;312:e241362.
    PubMed    
    
    
    
77. LIN F, Choyke PL
    Somatostatin Radioligand Therapy of Breast Cancer: A Target of Opportunity.
    Radiology. 2024;312:e241298.
    PubMed    
    
    
    
78. ULANER GA, VanderMolen LA, Li G, Ferreira D, et al
    Dotatate PET/CT and (225)Ac-Dotatate Therapy for Somatostatin Receptor-expressing Metastatic Breast Cancer.
    Radiology. 2024;312:e233408.
    PubMed     Abstract available
    
    
    
79. JOGI A, Johnson K, Wittgren S, Sundgren V, et al
    Assessing Digital Breast Tomosynthesis Impact on Early Cancer Detection: Insights from Consecutive Screening.
    Radiology. 2024;312:e233417.
    PubMed     Abstract available
    
    
    June 2024
80. LEE AY, Friedewald SM
    Clinical Implementation of AI in Screening Mammography: The Essential Role of Prospective Evaluation.
    Radiology. 2024;311:e241124.
    PubMed    
    
    
    
81. LAURITZEN AD, Lillholm M, Lynge E, Nielsen M, et al
    Early Indicators of the Impact of Using AI in Mammography Screening for Breast Cancer.
    Radiology. 2024;311:e232479.
    PubMed     Abstract available
    
    
    
82. GUO X, Zhou N, Liu J, Ding J, et al
    Comparison of an Affibody-based Molecular Probe and (18)F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT.
    Radiology. 2024;311:e232209.
    PubMed     Abstract available
    
    
    
83. MANN RM
    Breast Screening with US Transmission Imaging: A New Approach Yielding Old Results.
    Radiology. 2024;311:e241074.
    PubMed    
    
    
    
84. ULANER GA
    HER2-targeted PET for Patients with Breast Cancer: Scintillating Data.
    Radiology. 2024;311:e240814.
    PubMed    
    
    
    
85. YAMASHITA MW, Larsen LH, Perez J, Edwards AV, et al
    Comparison of Mammography and Mammography with Supplemental Whole-Breast US Tomography for Cancer Detection in Patients with Dense Breasts.
    Radiology. 2024;311:e231680.
    PubMed     Abstract available
    
    
    May 2024
86. TURKBEY B
    Use of Molecular Imaging to Further Investigate PI-RADS 3 Lesions.
    Radiology. 2024;311:e240401.
    PubMed    
    
    
    
87. POTSCH N, Sodano C, Baltzer PAT
    Performance of Diffusion-weighted Imaging-based Noncontrast MRI Protocols for Diagnosis of Breast Cancer: A Systematic Review and Meta-Analysis.
    Radiology. 2024;311:e232508.
    PubMed     Abstract available
    
    
    
88. KATAOKA M, Iima M
    Potential of the Diffusion-based Noncontrast Protocol for Breast Imaging: Current Status and Hints for Improvements.
    Radiology. 2024;311:e241058.
    PubMed    
    
    
    
89. NGUYEN DL, Ren Y, Jones TM, Thomas SM, et al
    Patient Characteristics Impact Performance of AI Algorithm in Interpreting Negative Screening Digital Breast Tomosynthesis Studies.
    Radiology. 2024;311:e232286.
    PubMed     Abstract available
    
    
    April 2024
90. KIM MK, Chang JM
    AI-driven Selection of Candidates for Supplemental Breast Cancer Screening.
    Radiology. 2024;311:e240447.
    PubMed    
    
    
    
91. LIU Y, Sorkhei M, Dembrower K, Azizpour H, et al
    Use of an AI Score Combining Cancer Signs, Masking, and Risk to Select Patients for Supplemental Breast Cancer Screening.
    Radiology. 2024;311:e232535.
    PubMed     Abstract available
    
    
    
92. BERG WA, Berg JM, Bandos AI, Vargo A, et al
    Addition of Contrast-enhanced Mammography to Tomosynthesis for Breast Cancer Detection in Women with a Personal History of Breast Cancer: Prospective TOCEM Trial Interim Analysis.
    Radiology. 2024;311:e231991.
    PubMed     Abstract available
    
    
    
93. COZZI A, Pinker K, Hidber A, Zhang T, et al
    BI-RADS Category Assignments by GPT-3.5, GPT-4, and Google Bard: A Multilanguage Study.
    Radiology. 2024;311:e232133.
    PubMed     Abstract available
    
    
    March 2024
94. DONNELLY J, Moffett L, Barnett AJ, Trivedi H, et al
    AsymMirai: Interpretable Mammography-based Deep Learning Model for 1-5-year Breast Cancer Risk Prediction.
    Radiology. 2024;310:e232780.
    PubMed     Abstract available
    
    
    
95. CHEN Y, Taib AG, Darker IT, James JJ, et al
    Erratum for: Performance of a Breast Cancer Detection AI Algorithm Using the Personal Performance in Mammographic Screening Scheme.
    Radiology. 2024;310:e249007.
    PubMed    
    
    
    
96. ZHOU LQ, Wu XL, Huang SY, Wu GG, et al
    Erratum for: Lymph Node Metastasis Prediction from Primary Breast Cancer US Images Using Deep Learning.
    Radiology. 2024;310:e249009.
    PubMed    
    
    
    
97. KUHL CK
    Abbreviated Breast MRI: State of the Art.
    Radiology. 2024;310:e221822.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.